Many thanks, Gralynchett, but one high question on ur central assumption: how does your delta go from 119% to 20% it is a very bearish growth forecast of yours? The developments have been quite positive & 20% would be a failure of the distribution, takeup, represent a consumer led avoidance & not augur well, it might be that CDC & other disease controllers in its other markets don't care about glutaraldehyde or sodium hypochlorite & prefer substitutes.
AUD/USD FX rate changes were not uniform this half-yearly & sales might not reflect the 2.88% change using the averages: the AUD/USD was more sticky until the very end of the 1/2 year (sales go on the usage on average (even disinfection/ sterilisation: in this case, use of Trophon).
Anyway, I would think at least 40% growth is achievable based on presentations, 2013 figures, CDC developments since half yearly 2013 & other deltas for similarly correlated biopharma stocks although disinfecting/ sterilising ultrasound probes r a little different to ur standard biopharma sales company. Trophon is incomparable in the sense that it is affected by CDC, disease monitoring in private/ public hospitals, CDC regulations.
GE might be a natural acquirer of NAN IMHO but DYOR. Depending on their knowledge of the Trophon takeup, they might make a bid for NAN after MLK Day (this year. MLK Day is Jan 19, tomorrow) when management get back from Aspen & Whistler. Execs would try to avoid sprained wrists walking round Cleveland/ slipping & sliding all over Ohio where GE Healthcare makes its' calls, so it will be a week or so maybe. If not, they miss the boat as the SP might get expensive if sales have rocketed again.
- Forums
- ASX - By Stock
- NAN
- Support Levels
Support Levels, page-16
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NAN (ASX) to my watchlist
|
|||||
Last
$2.83 |
Change
0.030(1.07%) |
Mkt cap ! $857.4M |
Open | High | Low | Value | Volume |
$2.87 | $2.87 | $2.82 | $3.640M | 1.284M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21844 | $2.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.85 | 3896 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21844 | 2.810 |
4 | 8337 | 2.800 |
3 | 7250 | 2.790 |
6 | 18965 | 2.780 |
2 | 1600 | 2.770 |
Price($) | Vol. | No. |
---|---|---|
2.850 | 3896 | 1 |
2.860 | 15133 | 3 |
2.870 | 5146 | 2 |
2.880 | 4588 | 2 |
2.890 | 1955 | 2 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NAN (ASX) Chart |